The risk of myocardial infarction associated with antihypertensive drug treatment in persons with uncomplicated essential hypertension

Pharmacotherapy

Volumn 16, Issue 3 I, 1996, Pages 321-326

  Jick, Hershel ^a,d   Derby, Laura E ^a   Gurewich, Victor ^b,c   Vasilakis, Catherine ^a  

^a BOSTON UNIVERSITY   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Boston Collab Drug Survlnc Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METHYLDOPA;

ACUTE HEART INFARCTION; ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; CORONARY RISK; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; FEMALE; GREAT BRITAIN; HUMANS; HYPERTENSION; INFORMATION SYSTEMS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PRODUCT SURVEILLANCE, POSTMARKETING; RISK ASSESSMENT;

EID: 0029941385     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction association with antihypertensive therapies. JAMA 1995;274:620-5.
2. Furberg CD, Psaty BM, Meyer JV. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-31.
3. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991;302:766-8.
4. Jick H, Terris BZ, Derby LE, Jick SS. Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiol Drug Safety 1992;1:347-9.
5. Jick H, Hall GC, Dean AD, Jick SS, Derby LE. A comparison of the risk of hypoglycemia between users of human and animal insulins. 1. Experience in the United Kingdom. Pharmacotherapy 1990;10:395-7.
6. Van Staa T, Abenheim L. The quality of information on a UK database of primary care records: a study of hospitalizalions due to hypoglycemia and other conditions. Pharmacoepidemiol Drug Safety 1994;3:15-21.
7. Garcia Rodriguez LA, Jick H. Comparison of the risk of gynaecomastia associated with cimetidine, omeprazole and other antiulcer medications. BMJ 1994;308:503-6.
8. Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 1995;346:1589-93.
9. Jick SS, Dean AD, Jick H. Antidepressants and fatal suicide. BMJ 1995;310:215-18
10. Garcia Rodriguez LA, Williams R, Derby LE, Dean AD, Jick H. Acute liver injury associated with non-steroidal antiinflammatory drugs and the role of risk factors. Arch Intern Med 1994;154:311-16.
11. Garcia Rodriguez LA, Jick H. The risk of upper gastrointestinal bleeding and/or perforation associated with individual nonsteroidal anti-inflammatory drugs. Lancet 1994;343:69-72.
12. Derby LE, Jick H, Henry DA, Dean AD. Cholestatic hepatitis associated with flucloxacillin. Med J Aust 1993;158:596-600.
13. Jick H, Derby, LE. A large population-based follow-up study of trimethoprim-sulfamelhoxazole, trimethoprim, and cephalexin users for certain uncommon serious drug toxicity. Pharmacotherapy 1995;15:428-32.
14. 1988 Joint National Committee. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1988;148:1023-38.
15. Swales JD, Ramsay LE, Coope JR, et al. Treating mild hypertension, agreement from the large trials: report of the British Hypertension Society working party. Br Med J 1989;298:694-8.
16. Sever P, Beevers G, Bulpitt C, et al. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. BMJ 1993;306:983-7.